FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martina Mirlacher

Research Profile

Procedures

Chemicals & Drugs

Physiology

Devices

Disorders

Genes & Molecular Sequences

Genes, erbB-2

Concepts & Ideas

Co-author Network

Publications

TOP 3
Achim Fleischmann; Hartwig Huland; Martina Mirlacher; Guido Sauter; Ronald Simon; W Wilczak; Andreas Erbersdobler; Thorsten Schlomm
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.
Pierre Tennstedt; Thomas Steuber; Andreas Brüchmann; Markus Graefen; Alexander Haese; Hartwig Huland; Patricia Köster; Sarah Minner; Martina Mirlacher; Guido Sauter; Thorsten Schlomm; Ronald Simon
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
Andreas Erbersdobler; Hendrik Isbarn; Kira Dix; Isabel Steiner; Thorsten Schlomm; Martina Mirlacher; Guido Sauter; Alexander Haese
Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martina Mirlacher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Achim Fleischmann; Hartwig Huland; Martina Mirlacher; Guido Sauter; Ronald Simon; W Wilczak; Andreas Erbersdobler; Thorsten Schlomm
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.
The Prostate 2012;72(9):991-7.
2012: Pierre Tennstedt; Thomas Steuber; Andreas Brüchmann; Markus Graefen; Alexander Haese; Hartwig Huland; Patricia Köster; Sarah Minner; Martina Mirlacher; Guido Sauter; Thorsten Schlomm; Ronald Simon
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
International journal of oncology 2012;40(1):261-8.
2010: Andreas Erbersdobler; Hendrik Isbarn; Kira Dix; Isabel Steiner; Thorsten Schlomm; Martina Mirlacher; Guido Sauter; Alexander Haese
Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
World journal of urology 2010;28(6):687-92.
2010: Andreas H Marx; Eike C Burandt; Matthias Choschzick; Ronald Simon; Emre F Yekebas; Jussuf T Kaifi; Martina Mirlacher; Djordje Atanackovic; Carsten Bokemeyer; Walter Fiedler; Luigi Terracciano; Guido Sauter; Jakob R Izbicki
Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.
Human pathology 2010;41(11):1577-85.
2010: Andreas H Marx; Margarete Zielinski; Charlotte-Marie Kowitz; Ana-Maria Dancau; Sabrina Thieltges; Ronald Simon; Matthias Choschzick; Emre F Yekebas; Jussuf T Kaifi; Martina Mirlacher; Djordje Atanackovic; Tim H Brümmendorf; Walter Fiedler; Carsten Bokemeyer; Jakob R Izbicki; Guido Sauter
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
Histopathology 2010;57(3):418-26.
2010: Sarah Minner; Birte Jessen; Lars Stiedenroth; Eike Burandt; Jens Köllermann; Martina Mirlacher; Andreas Erbersdobler; Christian Eichelberg; Margit Fisch; Tim H Brümmendorf; Carsten Bokemeyer; Ronald Simon; Thomas Steuber; Markus Graefen; Hartwig Huland; Guido Sauter; Thorsten Schlomm
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1553-60.
2010: Ronald Simon; Martina Mirlacher; Guido Sauter
Immunohistochemical analysis of tissue microarrays.
Methods in molecular biology (Clifton, N.J.) 2010;664():113-26.
2010: Martina Mirlacher; Ronald Simon
Recipient block TMA technique.
Methods in molecular biology (Clifton, N.J.) 2010;664():37-44.
2010: Ana-Maria Dancau; Ronald Simon; Martina Mirlacher; Guido Sauter
Tissue microarrays.
Methods in molecular biology (Clifton, N.J.) 2010;576():49-60.
2009: Andreas Erbersdobler; Hendrik Isbarn; Isabel Steiner; Thorsten Schlomm; Felix Chun; Martina Mirlacher; Guido Sauter
Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.
Urology 2009;74(5):1169-73.
2009: Achim Fleischmann; Thorsten Schlomm; Jens Köllermann; Nikolina Sekulic; Hartwig Huland; Martina Mirlacher; Guido Sauter; Ronald Simon; Andreas Erbersdobler
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
The Prostate 2009;69(9):976-81.
2009: Jozef Zustin; K Boddin; M C Tsourlakis; E Burandt; Martina Mirlacher; F Jaenicke; Jakob R Izbicki; W Ruether; Johannes M Rueger; Carsten Bokemeyer; Ronald Simon; Guido Sauter
HER-2/neu analysis in breast cancer bone metastases.
Journal of clinical pathology 2009;62(6):542-6.
2009: Andreas H Marx; Lars Tharun; Johanna Muth; Ana-Maria Dancau; Ronald Simon; Emre F Yekebas; Jussuf T Kaifi; Martina Mirlacher; Tim H Brümmendorf; Carsten Bokemeyer; Jakob R Izbicki; Guido Sauter
HER-2 amplification is highly homogenous in gastric cancer.
Human pathology 2009;40(6):769-77.
2009: Andreas Marx; Timo Wandrey; Philipp Simon; Agatha Wewer; Tobias Grob; Uta Reichelt; Sarah Minner; Ronald Simon; Martina Spehlmann; Wolfgang Tigges; Nib Soehendra; Uwe Seitz; Stefan Seewald; Jakob R Izbicki; Emre F Yekebas; Jussuf T Kaifi; Martina Mirlacher; Luigi Terracciano; Achim Fleischmann; Andreas Raedler; Guido Sauter
Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Human pathology 2009;40(2):166-73.
2008: Achim Fleischmann; Thorsten Schlomm; Hartwig Huland; Jens Köllermann; Philipp Simon; Martina Mirlacher; Georg Salomon; Felix H K Chun; Thomas Steuber; Ronald Simon; Guido Sauter; Markus Graefen; Andreas Erbersdobler
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7838-42.
2008: Andreas Marx; Philipp Simon; Ronald Simon; Martina Mirlacher; Jakob R Izbicki; Emre Yekebas; Jussuf T Kaifi; Luigi Terracciano; Guido Sauter
AMACR expression in colorectal cancer is associated with left-sided tumor localization.
Virchows Archiv : an international journal of pathology 2008;453(3):243-8.
2007: Khawla Al-Kuraya; Hedvika Novotny; Prashant Bavi; Abdul K Siraj; Shahab Uddin; Adnan Ezzat; Nasser Al Sanea; Fouad Al Dayel; Hadeel Al Mana; Salwa S Sheikh; Martina Mirlacher; Coya Tapia; Ronald Simon; Guido Sauter; Luigi Terracciano; Luigi Tornillo
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.
Journal of clinical pathology 2007;60(7):768-72.
2007: Matthias Woenckhaus; Lukas Bubendorf; Peter Dalquen; Julia Foerster; Hagen Blaszyk; Martina Mirlacher; Markus Soler; Wolfgang Dietmaier; Guido Sauter; Arndt Hartmann; Peter J Wild
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.
Journal of clinical pathology 2007;60(5):483-6.
2007: Thorsten Schlomm; Andreas Erbersdobler; Martina Mirlacher; Guido Sauter
Molecular staging of prostate cancer in the year 2007.
World journal of urology 2007;25(1):19-30.
2007: Coya Tapia; Katharina Glatz; Hedvika Novotny; Alessandro Lugli; Milo Horcic; Christian A Seemayer; Luigi Tornillo; Luigi Terracciano; Hanspeter Spichtin; Martina Mirlacher; Ronald Simon; Guido Sauter
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(2):192-8.
2006: Martin Oeggerli; Peter Schraml; C Ruiz; M Bloch; Hedvika Novotny; Martina Mirlacher; Guido Sauter; Ronald Simon
E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
Oncogene 2006;25(49):6538-43.
2006: Matthias D Hofer; Coya Tapia; Tara-Jane Browne; Martina Mirlacher; Guido Sauter; Mark A Rubin
Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue.
Archives of pathology & laboratory medicine 2006;130(7):989-96.
2006: Christian Ruiz; Silvia Seibt; Khawla Al-Kuraya; Abdul K Siraj; Martina Mirlacher; Peter Schraml; Robert Maurer; Hanspeter Spichtin; Joachim Torhorst; Savelina Popovska; Ronald Simon; Guido Sauter
Tissue microarrays for comparing molecular features with proliferation activity in breast cancer.
International journal of cancer. Journal international du cancer 2006;118(9):2190-4.
2006: Sylvia Stadlmann; Uwe Gueth; Ulrich Reiser; Pierre-André Diener; Alain G Zeimet; Edward Wight; Martina Mirlacher; Guido Sauter; Michael J Mihatsch; Gad Singer
Epithelial growth factor receptor status in primary and recurrent ovarian cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(4):607-10.
2006: Moritz Wyler von Ballmoos; Denise Dubler; Martina Mirlacher; Gieri Cathomas; Jürgen Muser; Barbara C Biedermann
Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):359-64.
2005: Michael F Press; Guido Sauter; Leslie Bernstein; Ivonne E Villalobos; Martina Mirlacher; Jian-Yuan Zhou; Rooba Wardeh; Yong-Tian Li; Roberta Guzman; Yanling Ma; Jane Sullivan-Halley; Angela Santiago; Jinha M Park; Alessandro Riva; Dennis J Slamon
Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6598-607.
2005: Alessandro Lugli; Hanspeter Spichtin; Robert Maurer; Martina Mirlacher; Jeff Kiefer; Pia Huusko; David Azorsa; Luigi Terracciano; Guido Sauter; Olli Kallioniemi; Spyro Mousses; Luigi Tornillo
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6450-8.
2005: Khawla Al-Kuraya; Peter Schraml; Salwa Sheikh; Samir S Amr; Joachim Torhorst; Coya Tapia; Hedvika Novotny; Hanspeter Spichtin; Robert Maurer; Martina Mirlacher; Ronald Simon; Guido Sauter
Predominance of high-grade pathway in breast cancer development of Middle East women.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(7):891-7.
2005: Tobias Zellweger; Christoph Ninck; Michael Bloch; Martina Mirlacher; Pasi A Koivisto; Heikki J Helin; Michael J Mihatsch; Thomas C Gasser; Lukas Bubendorf
Expression patterns of potential therapeutic targets in prostate cancer.
International journal of cancer. Journal international du cancer 2005;113(4):619-28.
2005: Doris Bösch; Mona Pache; Ronald Simon; Peter Schraml; Katharina Glatz; Martina Mirlacher; Josef Flammer; Guido Sauter; Peter Meyer
Expression and amplification of therapeutic target genes in retinoblastoma.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2005;243(2):156-62.
2005: Ronald Simon; Martina Mirlacher; Guido Sauter
Tissue microarrays.
Methods in molecular medicine 2005;114():257-68.
2004: Khawla Al-Kuraya; Peter Schraml; Joachim Torhorst; Coya Tapia; Boriana M Zaharieva; Hedvika Novotny; Hanspeter Spichtin; Robert Maurer; Martina Mirlacher; Ossi Köchli; Markus Zuber; Holger Dieterich; Friedrich Mross; Kim Wilber; Ronald Simon; Guido Sauter
Prognostic relevance of gene amplifications and coamplifications in breast cancer.
Cancer research 2004;64(23):8534-40.
2004: Coya Tapia; Peter Schraml; Ronald Simon; Khawla S Al-Kuraya; Robert Maurer; Martina Mirlacher; Hedvika Novotny; Hanspeter Spichtin; Michael J Mihatsch; Guido Sauter
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies.
International journal of oncology 2004;25(6):1551-7.
2004: Philip Thomas Went; Stephan Dirnhofer; Marcel Bundi; Martina Mirlacher; Peter Schraml; Sara Mangialaio; Sasa Dimitrijevic; Juha Kononen; Alessandro Lugli; Ronald Simon; Guido Sauter
Prevalence of KIT expression in human tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4514-22.
2004: Michael Fleiner; Marco Kummer; Martina Mirlacher; Guido Sauter; Gieri Cathomas; Reto Krapf; Barbara C Biedermann
Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis.
Circulation 2004;110(18):2843-50.
2004: Alessandro Lugli; Luigi Tornillo; Martina Mirlacher; Marcel Bundi; Guido Sauter; Luigi Terracciano
Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
American journal of clinical pathology 2004;122(5):721-7.
2004: Martina Mirlacher; Marlis Kasper; Martina Storz; Yvonne Knecht; Ursula Dürmüller; Ronald Simon; Michael J Mihatsch; Guido Sauter
Influence of slide aging on results of translational research studies using immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(11):1414-20.
2004: Vassil Kaimaktchiev; Luigi Terracciano; Luigi Tornillo; Hanspeter Spichtin; Dimitra Stoios; Marcel Bundi; Veselina Korcheva; Martina Mirlacher; Massimo Loda; Guido Sauter; Christopher L Corless
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(11):1392-9.
2004: Gilbert Spizzo; Philip Thomas Went; Stephan Dirnhofer; Peter Obrist; Ronald Simon; Hanspeter Spichtin; Robert Maurer; Urs Metzger; Brida von Castelberg; Rahel Bart; Shanna Stopatschinskaya; Ossi Robert Köchli; Philip Haas; Friedrich Mross; Markus Zuber; Holger Dietrich; Susanne Bischoff; Martina Mirlacher; Guido Sauter; Guenther Gastl
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
Breast cancer research and treatment 2004;86(3):207-13.
2004: Min Zheng; Ronald Simon; Martina Mirlacher; Robert Maurer; Thomas Gasser; Thomas Forster; Pierre-André Diener; Michael J Mihatsch; Guido Sauter; Peter Schraml
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
The American journal of pathology 2004;165(1):63-9.
2004: Kirsten Struckmann; Peter Schraml; Ronald Simon; Katja Elmenhorst; Martina Mirlacher; Juha Kononen; Holger Moch
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Cancer research 2004;64(5):1632-8.
2004: Ronald Simon; Martina Mirlacher; Guido Sauter
Tissue microarrays.
Methods in molecular medicine 2004;97():377-89.
2004: Philip Thomas Went; Alessandro Lugli; Sandra Meier; Marcel Bundi; Martina Mirlacher; Guido Sauter; Stephan Dirnhofer
Frequent EpCam protein expression in human carcinomas.
Human pathology 2004;35(1):122-8.
2004: Ronald Simon; Martina Mirlacher; Guido Sauter
Tissue microarrays.
BioTechniques 2004;36(1):98-105.
2004: Ronald Simon; Soti Panussis; Robert Maurer; Hanspeter Spichtin; Katharina Glatz; Coya Tapia; Martina Mirlacher; Alex Rufle; Joachim Torhorst; Guido Sauter
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):178-83.
2003: Mona Pache; Katharina Glatz; Doris Bösch; Stephan Dirnhofer; Martina Mirlacher; Ronald Simon; Peter Schraml; Alex Rufle; Josef Flammer; Guido Sauter; Peter Meyer
Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays.
Virchows Archiv : an international journal of pathology 2003;443(6):741-4.
2003: Alessandro Lugli; Yvonne Forster; Philippe Haas; Antonio Nocito; christoph bucher; Heidi Bissig; Martina Mirlacher; Martina Storz; Michael J Mihatsch; Guido Sauter
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
Human pathology 2003;34(10):994-1000.
2003: Ronald Simon; Martina Mirlacher; Guido Sauter
Tissue microarrays in cancer diagnosis.
Expert review of molecular diagnostics 2003;3(4):421-30.
2003: Tobias Zellweger; Christoph Ninck; Martina Mirlacher; Matthias Annefeld; Andrew G. Glass; Thomas C Gasser; Michael J Mihatsch; Edward P Gelmann; Lukas Bubendorf
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.
The Prostate 2003;55(1):20-9.
2002: Martin Bolli; Thomas Kocher; Michel Adamina; Ulrich Guller; Peter Dalquen; Philippe Haas; Martina Mirlacher; Franco Gambazzi; Felix Harder; Michael Heberer; Guido Sauter; Giulio C Spagnoli
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Annals of surgery 2002;236(6):785-93; discussion 793.
1999: Holger Moch; Peter Schraml; Lukas Bubendorf; Martina Mirlacher; Juha Kononen; Thomas Gasser; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
The American journal of pathology 1999;154(4):981-6.
1999: Holger Moch; Peter Schraml; Lukas Bubendorf; Martina Mirlacher; Juha Kononen; Thomas Gasser; Michael J Mihatsch; Olli Kallioniemi; Guido Sauter
[Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1999;83():225-32.